OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
December 02, 2022
Dissolution testing is experiencing a refresh thanks to a variety of market drivers.
September 20, 2022
Experts from Umoja Biopharma dive into cell therapy development in this episode of the Drug Solutions Podcast, including the greatest advancements in cell therapy to date, areas for improvement, the biggest trends in cell therapy development, and retention as a pain point.
July 02, 2022
As we reach further afield in the molecular universe, we encounter new types of problems to resolve.
June 21, 2022
Avid Bioservices has expanded its viral vector development and manufacturing facility with the addition of analytical and process development suites.
May 16, 2022
Flexible and efficient methods are needed for biopharmaceutical manufacturing.
May 03, 2022
Digital maintenance solutions can help visualize the value and key activities provided by the equipment vendor from inception to utilization.
March 03, 2022
Developers need to consider key challenges when approaching accelerated formulation strategies to ensure success.
February 22, 2022
Noema Pharma announces first patient dosed in its Phase IIb clinical trial of mGluR5 inhibitor NOE-101 in trigeminal neuralgia.
February 03, 2022
Although mRNA and viral vector vaccines have been top of mind for COVID-19 treatments, other technologies and treatments are emerging—along with new variants.
February 01, 2022
Experience is an invaluable asset for outsourcing partners, particularly as more challenging method development services are in demand.